Aiman Shalabi
- Oncology top 10%
- Immunology
- Public Health, Environmental and Occupational Health
- Pulmonary and Respiratory Medicine
- Pediatrics, Perinatology and Child Health
- Co-authors
- Ramy IbrahimRoss StewartLaura PearceVanessa M. Hubbard-LuceyJun TangJill O’Donnell-TormeyDiane E. ColePercy Ivy
- Topics
- CAR-T cell therapy research (10 papers)Immunotherapy and Immune Responses (5 papers)Cancer Immunotherapy and Biomarkers (5 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaNature Reviews Drug Discovery
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Aiman Shalabi
16 papers receiving 513 citations
Peers
Comparison fields: 5 of 78
- Oncology 273
- Immunology 122
- Public Health, Environmental and Occupational Health 103
- Pulmonary and Respiratory Medicine 88
- Pediatrics, Perinatology and Child Health 66
Countries citing papers authored by Aiman Shalabi
This map shows the geographic impact of Aiman Shalabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aiman Shalabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aiman Shalabi more than expected).
Fields of papers citing papers by Aiman Shalabi
This network shows the impact of papers produced by Aiman Shalabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aiman Shalabi. The network helps show where Aiman Shalabi may publish in the future.
Co-authorship network of co-authors of Aiman Shalabi
This figure shows the co-authorship network connecting the top 25 collaborators of Aiman Shalabi. A scholar is included among the top collaborators of Aiman Shalabi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aiman Shalabi. Aiman Shalabi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | 8 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 8 | |
| 9 | 61 | |
| 10 | 76 | |
| 11 | 21 | |
| 12 | 85 | |
| 13 | 3 | |
| 14 | 106 | |
| 15 | 2 | |
| 16 | 39 | |
| 17 | 96 |
About Aiman Shalabi
Aiman Shalabi is a scholar working on Oncology, Immunology and Geriatrics and Gerontology, having authored 17 papers that have together received 526 indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Immunotherapy and Immune Responses (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Geriatrics and Gerontology (56 citations), Oncology (273 citations) and Emergency Medical Services (56 citations). Aiman Shalabi has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Ramy Ibrahim, Ross Stewart, Laura Pearce, Vanessa M. Hubbard-Lucey, Jun Tang, Jill O’Donnell-Tormey, Diane E. Cole, Percy Ivy, Matthew Boron and Frank M. Balis. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nature Reviews Drug Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.